| Product NDC: | 67457-190 |
| Proprietary Name: | Enlon |
| Non Proprietary Name: | edrophonium chloride |
| Active Ingredient(s): | 10 mg/mL & nbsp; edrophonium chloride |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 67457-190 |
| Labeler Name: | Mylan Institutional LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA088873 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130422 |
| Package NDC: | 67457-190-15 |
| Package Description: | 1 VIAL, GLASS in 1 CARTON (67457-190-15) > 15 mL in 1 VIAL, GLASS |
| NDC Code | 67457-190-15 |
| Proprietary Name | Enlon |
| Package Description | 1 VIAL, GLASS in 1 CARTON (67457-190-15) > 15 mL in 1 VIAL, GLASS |
| Product NDC | 67457-190 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | edrophonium chloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20130422 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional LLC |
| Substance Name | EDROPHONIUM CHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |